How the receptor FSHR-1 helps nerves and muscles communicate during normal and stress conditions

Investigation of the role of the G protein-coupled receptor FSHR-1 in multi-tissue control of neuromuscular signaling in normal and oxidative stress conditions

NIH-funded research Butler University · NIH-11221240

This project looks at whether a receptor called FSHR-1 helps protect nerve-to-muscle signaling from oxidative stress that can contribute to conditions like Alzheimer’s disease.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionButler University NIH-funded
Lab location1 site (Indianapolis, United States)
Project IDNIH-11221240 on NIH RePORTER

What this research studies

Researchers will use the roundworm C. elegans to change or remove the FSHR-1 receptor in specific tissues such as the intestine and glial cells and then watch how nerve-to-muscle communication and movement change. They will expose worms to oxidative stress and compare signaling and behavior under normal and stressed conditions to map which tissues and molecules are involved. The team will test candidate signaling partners and downstream effectors to trace how signals travel between tissues to affect cholinergic motor neurons and muscle activity. Results aim to define molecular steps that could later guide treatments for human neurodegenerative conditions linked to oxidative damage.

Who could benefit from this research

Good fit: This project does not enroll people because it is laboratory research in worms, though future clinical work informed by these findings would likely focus on patients with Alzheimer’s or other neurodegenerative diseases involving oxidative stress.

Not a fit: Patients seeking immediate treatment or participation will not benefit directly from this grant because it conducts basic experiments in a non-human model.

Why it matters

Potential benefit: If successful, the work could reveal molecular targets to protect synapses and slow nerve damage in conditions like Alzheimer’s disease.

How similar studies have performed: Related studies in model organisms have shown that GPCR signaling and oxidative stress affect synaptic function, but the specific role of FSHR-1 in multi-tissue control is a newer, less-tested area.

Where this research is happening

Indianapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.